T3D Therapeutics, Inc. logo

T3D Therapeutics, Inc.

T3D Therapeutics Inc. is a privately-held Research Triangle Park, NC-based company, committed to develop and commercialize disease remedial therapeutics for the treatment of Alzheimers disease and other CNS disorders.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.t3dtherapeutics.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address
68 T.W. Alexander Drive PO Box 13628, NC 27709
Research Triangle Park
United States
Email
Contact Number
+1 919-237-4897

In June 2013, Dara Biosciences granted T3D Therapeutics, the exclusive worldwide rights to develop and commercialize DB959 / T3D-959. DARA had previously developed DB959 through Phase 1 clinical trials for the treatment of diabetes and dyslipidemia.

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/t3d-therapeutics-inc.” connections=”true” suffix=””]

In Mar 2015, T3D Therapeutics awarded SBIR Phase 2 grant from The National Institute on Aging for clinical development of T3D- 959.